We documented that CSF1R inhibition impedes mesothelioma progression, abrogates macrophage tumor infiltration, polarizes the remaining ones towards an M1 anti-tumor phenotype and activates tumor dendritic and T cells. Here, CSF1R is linked to neoplasm.